AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

TFESI and Neuropathic Pain in Lumbosacral Radiculopathy

RecruitingNAAges 18 Years - 65 YearsAllMarmara University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Patients with lumbosacral radiculopathy frequently experience neuropathic pain due to nerve root compression. Transforaminal epidural steroid injection (TFESI) is commonly used for pain relief in these patients. This study aims to evaluate the effect of TFESI on neuropathic pain severity using the Neuropathic Pain Scale (NPS) in patients with lumbosacral radiculopathy. Clinical outcomes before and after the procedure will be compared.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 years and older * Patients diagnosed with lumbosacral radiculopathy based on clinical evaluation and lumbar MRI findings * Presence of neuropathic pain symptoms associated with lumbosacral radiculopathy * Patients scheduled to undergo transforaminal epidural steroid injection (TFESI) * Patients able to understand and complete the study questionnaires and scales * Voluntary written informed consent provided Exclusion Criteria: * Previous lumbar spinal surgery * Cauda equina syndrome or progressive neurological deficit * Spinal malignancy, infection, or acute vertebral fracture * Pregnancy or breastfeeding * Coagulation disorders or current anticoagulant therapy contraindicating injection procedures * Known allergy to contrast agents, local anesthetics, or corticosteroids * Severe uncontrolled systemic disease * Cognitive impairment preventing completion of assessment scales * Patients unwilling to participate or unable to attend follow-up visits
๐Ÿ’Š

What it tests

  • Transforaminal Epidural Steroid Injections
๐Ÿ“

Where

1 site
Marmara University Pendik Training and Research Hospital, Department of Physical Medicine and Rehabilitation"
Istanbul, Turkey (Tรผrkiye)
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy